Binxian Wei - Jun 11, 2023 Form 4 Insider Report for PALISADE BIO, INC. (PALI)

Role
Director
Signature
/s/ Binxian Wei
Stock symbol
PALI
Transactions as of
Jun 11, 2023
Transactions value $
$0
Form type
4
Date filed
6/13/2023, 06:44 PM
Previous filing
Feb 10, 2022
Next filing
Nov 24, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PALI Restricted Stock Units Award $0 +6.98K $0.00 6.98K Jun 11, 2023 Common Stock 6.98K Direct F1, F2, F3, F4
transaction PALI Common Stock Options Award $0 +9.58K $0.00 9.58K Jun 11, 2023 Common Stock 9.58K $1.60 Direct F1, F2, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents partial compensation for services rendered as a director pursuant to Issuer's director compensation policy, which includes 5,100 restricted stock units and 7,000 common stock purchase options. The grants were issued from the Issuer's 2021 Equity Incentive Plan. In addition, Reporting Person received, per its election, an additional 1,880 restricted stock units and 2,580 common stock purchase options as a discretionary grant.
F2 The grants vest fully on the one (1) year anniversary of the grant date.
F3 Each restricted stock unit represents the right to receive one share of common stock.
F4 N/A
F5 Each option represents the right to purchase one share of common stock at the exercise price.